IN SB0088 | 2022 | Regular Session

Status

Spectrum: Slight Partisan Bill (Republican 5-2)
Status: Engrossed on February 1 2022 - 50% progression, died in committee
Action: 2022-02-10 - Representative Shackleford added as cosponsor
Pending: House Financial Institutions and Insurance Committee
Text: Latest bill text (Engrossed) [PDF]

Summary

Prescription drug rebates and pricing. Provides that, for individual health insurance coverage, the defined cost sharing for a prescription drug be calculated at the point of sale and based on a price that is reduced by an amount equal to at least 85% of all rebates received by the insurer in connection with the dispensing or administration of the prescription drug. Requires that, for group health insurance coverage, an insurer: (1) pass through to a plan sponsor 100% of all rebates received or estimated to be received by the insurer concerning the dispensing or administration of prescription drugs to the covered individuals of the plan sponsor; (2) provide a plan sponsor, at the time of contracting, the option of calculating defined cost sharing for covered individuals of the plan sponsor at the point of sale based on a price that is reduced by some or all of the rebates received or estimated to be received by the insurer concerning the dispensing or administration of the prescription drug; and (3) disclose specified information to the plan sponsor. Allows the department of insurance to enforce the provisions and impose a civil penalty.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Prescription drug rebates and pricing.

Sponsors


Roll Calls

2022-01-31 - Senate - Senate - Third reading (Y: 31 N: 18 NV: 0 Abs: 0) [PASS]
2022-01-19 - Senate - Senate - Committee Vote (Y: 7 N: 4 NV: 0 Abs: 1) [PASS]

History

DateChamberAction
2022-02-10HouseRepresentative Shackleford added as cosponsor
2022-02-07HouseFirst reading: referred to Committee on Financial Institutions and Insurance
2022-02-01SenateReferred to the House
2022-01-31SenateSenator Bohacek added as coauthor
2022-01-31SenateCosponsor: Representative Vermilion A
2022-01-31SenateHouse sponsor: Representative Barrett
2022-01-31SenateThird reading: passed; Roll Call 102: yeas 31, nays 18
2022-01-27SenateAmendment #6 (Charbonneau) prevailed; voice vote
2022-01-27SenateSecond reading: amended, ordered engrossed
2022-01-20SenateCommittee report: do pass, adopted
2022-01-18SenateSenator Ford J.D. added as coauthor
2022-01-06SenateSenator Becker added as second author
2022-01-04SenateFirst reading: referred to Committee on Health and Provider Services
2022-01-04SenateAuthored by Senator Charbonneau

Indiana State Sources

TypeSource
Summaryhttps://iga.in.gov/legislative/2022/bills/senate/88/details
Texthttp://iga.in.gov/static-documents/3/a/4/c/3a4ca9d5/SB0088.01.INTR.pdf
Texthttp://iga.in.gov/static-documents/a/f/c/5/afc55d29/SB0088.01.INTR.pdf
Texthttp://iga.in.gov/static-documents/b/8/0/d/b80dd0ad/SB0088.02.COMS.pdf
Texthttp://iga.in.gov/static-documents/f/7/d/5/f7d57e9f/SB0088.02.COMS.pdf
Texthttp://iga.in.gov/static-documents/c/6/5/b/c65bd55e/SB0088.03.ENGS.pdf
Amendmenthttp://iga.in.gov/static-documents/1/9/5/e/195e1c60/SB0088.02.COMS.AMS001.pdf
Amendmenthttp://iga.in.gov/static-documents/0/3/6/3/0363c064/SB0088.02.COMS.AMS002.pdf
Amendmenthttp://iga.in.gov/static-documents/3/e/3/d/3e3df783/SB0088.02.COMS.AMS003.pdf
Amendmenthttp://iga.in.gov/static-documents/8/2/6/0/82608499/SB0088.02.COMS.AMS004.pdf
Amendmenthttp://iga.in.gov/static-documents/2/9/7/8/2978d6bd/SB0088.02.COMS.AMS005.pdf
Amendmenthttp://iga.in.gov/static-documents/0/f/0/0/0f004ca7/SB0088.02.COMS.AMS006.pdf
Supplementhttp://iga.in.gov/static-documents/0/d/0/b/0d0bed78/SB0088.01.INTR.FN001.pdf
Supplementhttp://iga.in.gov/static-documents/e/f/6/2/ef62da3f/SB0088.01.INTR.CRS001.pdf
Supplementhttp://iga.in.gov/static-documents/7/e/6/8/7e68fd2f/SB0088.02.COMS.FN001.pdf
Supplementhttp://iga.in.gov/static-documents/1/d/3/a/1d3a342d/SB0088.03.ENGS.FN001.pdf
Supplementhttp://iga.in.gov/static-documents/6/9/f/8/69f8bc35/SB0088.03.ENGS.FN002.pdf
Roll Callhttp://iga.in.gov/static-documents/a/2/9/2/a29208de/SB0088.01.INTR.01.pdf
Roll Callhttp://iga.in.gov/static-documents/0/1/8/8/0188b45c/SB0088.102_S.pdf

Bill Comments

feedback